Lavima Fertility provides CAPA‑IVM, a patented in‑vitro maturation technology that matures oocytes outside the body without systemic ovarian stimulation or an hCG trigger.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional IVF requires multiple days of systemic ovarian stimulation with gonadotropins and an hCG trigger, exposing patients to hormonal side effects, increased treatment burden, and higher costs. This approach can be unsuitable for women with infertility, those undergoing cancer treatment, or individuals seeking egg freezing without extensive hormone exposure.
Solution
Lavima Fertility offers CAPA‑IVM, a patented in‑vitro maturation (IVM) technology that matures oocytes outside the body after minimal or no ovarian stimulation. By retaining high intrafollicular cAMP levels during oocyte capacitation, the method enhances developmental competence without the need for systemic hormones or a trigger injection. Clinical data show live‑birth rates comparable to conventional IVF and no adverse effects on child development up to two years. CAPA‑IVM can be applied for standard IVF cycles, fertility preservation in cancer patients, and elective egg freezing for women aged 30‑34, providing a safer, lower‑burden alternative to traditional protocols.
Target Audience
Primary customers are infertile women seeking IVF or egg freezing without hormonal stimulation, and female cancer patients requiring fertility preservation before chemotherapy or radiation.
Features
- No systemic ovarian stimulation or hCG trigger required, eliminating hormone‑related side effects
- Biphasic IVM process with a capacitation step that maintains high cAMP levels to improve oocyte quality
- Proven clinical efficacy with live‑birth rates equivalent to conventional IVF and favorable 2‑year infant developmental outcomes
- Applicable for infertility treatment, fertility preservation in oncology patients, and elective egg freezing
- Patented technology owned by Lavima Fertility, supported by peer‑reviewed publications (Human Reproduction 2020, 2022)